ロード中...
Biological therapy for ulcerative colitis: An update
Of the diverse biological agents used for patients with ulcerative colitis, the anti-tumor necrosis factor-α agents infliximab and adalimumab have been used in large-scale clinical trials and are currently widely used in the treatment of inflammatory bowel disease patients. Recent studies have indic...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4188881/ https://ncbi.nlm.nih.gov/pubmed/25309060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i37.13234 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|